These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9470127)
1. PET and the investigation of dementia in the parkinsonian patient. Turjanski N; Brooks DJ J Neural Transm Suppl; 1997; 51():37-48. PubMed ID: 9470127 [TBL] [Abstract][Full Text] [Related]
2. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445 [TBL] [Abstract][Full Text] [Related]
3. FDG PET imaging in patients with pathologically verified dementia. Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505 [TBL] [Abstract][Full Text] [Related]
4. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Albin RL; Minoshima S; D'Amato CJ; Frey KA; Kuhl DA; Sima AA Neurology; 1996 Aug; 47(2):462-6. PubMed ID: 8757021 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. Zhao P; Zhang B; Gao S Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism. Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141 [TBL] [Abstract][Full Text] [Related]
7. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease. Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078 [TBL] [Abstract][Full Text] [Related]
15. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M; Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266 [TBL] [Abstract][Full Text] [Related]
16. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780 [TBL] [Abstract][Full Text] [Related]
17. Image analysis of neuropil threads in Alzheimer's, Pick's, diffuse Lewy body disease and in progressive supranuclear palsy. Davis DG; Wang HZ; Markesbery WR J Neuropathol Exp Neurol; 1992 Nov; 51(6):594-600. PubMed ID: 1336541 [TBL] [Abstract][Full Text] [Related]
18. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614 [TBL] [Abstract][Full Text] [Related]
19. FDG PET and differential diagnosis of dementia. Herholz K Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624 [TBL] [Abstract][Full Text] [Related]
20. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease. Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]